What type of Hepatitis C is Zepatier used to treat?
Zepatier (elbasvir and grazoprevir) is used to treat chronic hepatitis C (HCV) genotype 1 or 4 infection in adults and children 12 years of age and older or weighing at least 66 pounds (30 kilograms).
Zepatier is given with or without ribavirin for HCV in patients with genotype 1 (the most common, 70% of HCV patients) or 4 (the least common, ~1% of HCV patients).
Zepatier is used only if your HCV has these specific genetic markers, for which your doctor will test.
In clinical trials, cure rates at 12 weeks ranged from 94 to 97 percent in genotype 1 and from 97 to 100 percent in genotype 4-infected subjects.
Zepatier tablets are taken once daily with or without food.
The most common side effects of Zepatier without ribavirin include fatigue, headache and nausea.
The most common side effects of Zepatier with ribavirin include anemia and headache.
See What are the new drugs for the treatment of hepatitis C?
Read next
What are the new drugs for the treatment of hepatitis C?
The newest drugs for the treatment of hepatitis C include Mavyret (glecaprevir and pibrentasvir), Vosevi (sofosbuvir, velpatasvir, and voxilaprevir), and Epclusa (sofosbuvir and velpatasvir). All are FDA-approved for the treatment of chronic hepatitis C virus (HCV) genotype 1, 2, 3, 4, 5 or 6 infection without cirrhosis or with compensated cirrhosis (Child-Pugh A), as well as other uses. Continue reading
What is the difference between hepatitis B and C?
Some of the main differences between hepatitis B and C are:
- Hepatitis B virus can be prevented with a vaccine, but not hepatitis C.
- Hepatitis B and C are different viruses, but you can have both hepatitis B and hepatitis C at the same time.
- Over 90% of people infected with hepatitis C who have not received treatment can be cured with 8 to 12 weeks of oral medications, but treatment for hepatitis B, if needed, may be long-term or lifelong.
- There is no cure for hepatitis B, but once you recover from acute hepatitis B, you develop antibodies that protect you from the virus for life.
Does Epclusa cure Hep C, what is the success rate?
Epclusa has a 98% overall cure rate in all 6 of the main types of hepatitis C in patients without cirrhosis (a serious liver disease) or with compensated cirrhosis (mild or no symptoms). Continue reading
Related medical questions
- What types of Hepatitis C does Mavyret treat?
- What types of hepatitis C (HCV) does Vosevi treat?
- How much does Harvoni cost and does health insurance cover it?
- How contagious is hepatitis C and how do you prevent it?
- Does Mavyret cure hep C (HCV)? What is the success rate?
- What is the cost of Sovaldi? Why is it so expensive?
- How long is an Epclusa treatment?
- Why there is no vaccine for hepatitis C?
- How long can hepatitis C live outside the body?
- What causes hepatitis C - how do you get or catch it?
- Is the hepatitis C virus curable?
- Are the symptoms the same for hepatitis B and C?
- How much does Vosevi cost?
- What is a "Hepatitis C Genotype" and why is it important?
- How well does Sovaldi work?
Drug information
- Zepatier Information for Consumers
- Zepatier prescribing info & package insert (for Health Professionals)
- Side Effects of Zepatier (detailed)
Related support groups
- Zepatier (2 questions, 18 members)
- Hepatitis C (49 questions, 691 members)
